Table 2.
Disease comparison in the basophilia group versus the non-basophilia control group.
| Disease | Basophilia Group (n = 224) |
Non-Basophilia Control Group (n = 224) |
|||
|---|---|---|---|---|---|
| Proportion | n | Proportion | n | p Value | |
| Inflammation | 65% | 145 | 36% | 80 | <0.0001 |
| Eosinophilic lung disease | 11% | 25 | 0 | 0 | <0.0001 |
| Parasitic disease | 6% | 14 | 1% | 2 | 0.004 |
| IBD | 6% | 13 | 1% | 3 | 0.02 |
| IMHA | 5% | 11 | 3% | 6 | 0.32 |
| Bronchitis | 3% | 7 | 1% | 2 | 0.18 |
| GI perforation/dehiscence | 3% | 6 | 1% | 2 | 0.29 |
| Pancreatitis | 2% | 5 | 2% | 4 | 1 |
| Pemphigus foliaceus | 2% | 5 | 0% | 0 | 0.06 |
| Other inflammatory conditions | 26% | 59 | 27% | 61 | 0.92 |
| Neoplasia | 32% | 72 | 31% | 69 * | 0.84 |
| Lymphoma | 10% | 23 | 16% | 36 | 0.09 |
| Mast cell tumor | 9% | 21 | 3% | 6 | 0.005 |
| Leukemia/MPNs | 4% | 9 | 0% | 0 | 0.004 |
| Mesenchymal neoplasia | 4% | 8 | 4% | 9 * | 1 |
| Epithelial neoplasia | 3% | 7 | 7% | 15 * | 0.12 |
| Other neoplasia | 2% | 4 | 2% | 4 | 1 |
| Other | 3% | 7 | 33% | 75 | <0.0001 |
* One dog was diagnosed with both biliary carcinoma and hemangiosarcoma and included in both mesenchymal and epithelial neoplasia.